Goldman Sachs’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Buy |
290,577
+6,243
| +2% | +$85.5K | ﹤0.01% | 2961 |
|
|
2025
Q1 | $3.14M | Sell |
284,334
-33,188
| -10% | -$367K | ﹤0.01% | 3067 |
|
|
2024
Q4 | $3.38M | Buy |
317,522
+1,565
| +0.5% | +$16.7K | ﹤0.01% | 3142 |
|
|
2024
Q3 | $4.01M | Buy |
315,957
+52,351
| +20% | +$665K | ﹤0.01% | 2907 |
|
|
2024
Q2 | $4.42M | Buy |
263,606
+149,744
| +132% | +$2.51M | ﹤0.01% | 2697 |
|
|
2024
Q1 | $1.71M | Sell |
113,862
-359
| -0.3% | -$5.39K | ﹤0.01% | 3295 |
|
|
2023
Q4 | $1.71M | Buy |
114,221
+60,574
| +113% | +$909K | ﹤0.01% | 3305 |
|
|
2023
Q3 | $752K | Buy |
53,647
+22,264
| +71% | +$312K | ﹤0.01% | 3683 |
|
|
2023
Q2 | $325K | Sell |
31,383
-39,172
| -56% | -$405K | ﹤0.01% | 4198 |
|
|
2023
Q1 | $652K | Buy |
70,555
+47,080
| +201% | +$435K | ﹤0.01% | 3932 |
|
|
2022
Q4 | $208K | Sell |
23,475
-117
| -0.5% | -$1.04K | ﹤0.01% | 4485 |
|
|
2022
Q3 | $196K | Sell |
23,592
-14,643
| -38% | -$122K | ﹤0.01% | 4732 |
|
|
2022
Q2 | $313K | Sell |
38,235
-11,495
| -23% | -$94.1K | ﹤0.01% | 4677 |
|
|
2022
Q1 | $434K | Sell |
49,730
-4,243
| -8% | -$37K | ﹤0.01% | 4658 |
|
|
2021
Q4 | $513K | Sell |
53,973
-3,207
| -6% | -$30.5K | ﹤0.01% | 4504 |
|
|
2021
Q3 | $962K | Sell |
57,180
-11,851
| -17% | -$199K | ﹤0.01% | 4004 |
|
|
2021
Q2 | $1.05M | Sell |
69,031
-34,368
| -33% | -$525K | ﹤0.01% | 3978 |
|
|
2021
Q1 | $2.01M | Sell |
103,399
-71,893
| -41% | -$1.4M | ﹤0.01% | 3364 |
|
|
2020
Q4 | $3.16M | Buy |
175,292
+15,706
| +10% | +$283K | ﹤0.01% | 2778 |
|
|
2020
Q3 | $3.08M | Buy |
159,586
+16,321
| +11% | +$315K | ﹤0.01% | 2673 |
|
|
2020
Q2 | $3.74M | Buy |
143,265
+23,728
| +20% | +$620K | ﹤0.01% | 2502 |
|
|
2020
Q1 | $2.13M | Buy |
119,537
+25,562
| +27% | +$456K | ﹤0.01% | 2720 |
|
|
2019
Q4 | $3.14M | Sell |
93,975
-32,749
| -26% | -$1.09M | ﹤0.01% | 2694 |
|
|
2019
Q3 | $3.02M | Buy |
126,724
+69,077
| +120% | +$1.65M | ﹤0.01% | 2608 |
|
|
2019
Q2 | $2.07M | Sell |
57,647
-1,798
| -3% | -$64.6K | ﹤0.01% | 2794 |
|
|
2019
Q1 | $2.2M | Buy |
59,445
+43,266
| +267% | +$1.6M | ﹤0.01% | 2896 |
|
|
2018
Q4 | $697K | Buy |
16,179
+3,945
| +32% | +$170K | ﹤0.01% | 3289 |
|
|
2018
Q3 | $578K | Sell |
12,234
-2,938
| -19% | -$139K | ﹤0.01% | 3405 |
|
|
2018
Q2 | $755K | Sell |
15,172
-29,527
| -66% | -$1.47M | ﹤0.01% | 3339 |
|
|
2018
Q1 | $2.22M | Buy |
44,699
+38,399
| +610% | +$1.91M | ﹤0.01% | 2820 |
|
|
2017
Q4 | $234K | Buy |
+6,300
| New | +$234K | ﹤0.01% | 3763 |
|